Pharmaceuticals Global Group of Eight (G8) Industry Guide_2016

LONDON, Oct. 24, 2016 /PRNewswire/ --

Summary
The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Synopsis
Essential resource for top-line data and analysis covering the G8 pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Reasons To Buy
- What was the size of the G8 pharmaceuticals market by value in 2015?
- What will be the size of the G8 pharmaceuticals market in 2020?
- What factors are affecting the strength of competition in the G8 pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the G8 pharmaceuticals market?

Key Findings
- G8 countries contributed $619.3 billion in 2015 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.9% between 2011 and 2015. The G8 countries are expected to reach a value of $712.2 billion in 2020, with a CAGR of 2.8% over the 2015-20 period.

- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $383.8 billion in 2015. This was followed by Japan and Germany, with a value of $81.2 and $33.9 billion, respectively.

- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $422.9 billion in 2016, followed by Japan and Germany with expected values of $81.7 and $46.4 billion, respectively.
Download the full report: https://www.reportbuyer.com/product/4242043/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com